We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · May 30, 2014

FGFR1/3 Fusions Define Unique Molecular Subtype of NSCLC

Clinical Cancer Research


Additional Info

Clinical Cancer Research
FGFR1/3 Tyrosine Kinase Fusions Define a Unique Molecular Subtype of Non-Small Cell Lung Cancer
Clin. Cancer Res 2014 May 21;[EPub Ahead of Print], R Wang, L Wang, Y Li, H Hu, L Shen, X-X Shen, Y Pan, T Ye, Y Zhang, X Luo, Y Zhang, B Pan, B Li, H Li, J Zhang, W Pao, H Ji, Y Sun, H Chen

Further Reading